Compare with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZIM LABORATORIES vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZIM LABORATORIES SUN PHARMA ZIM LABORATORIES/
SUN PHARMA
 
P/E (TTM) x 38.1 33.9 112.3% View Chart
P/BV x 2.1 4.7 45.5% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 ZIM LABORATORIES   SUN PHARMA
EQUITY SHARE DATA
    ZIM LABORATORIES
Mar-21
SUN PHARMA
Mar-21
ZIM LABORATORIES/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs131654 20.1%   
Low Rs53339 15.6%   
Sales per share (Unadj.) Rs189.2139.6 135.5%  
Earnings per share (Unadj.) Rs4.59.5 47.3%  
Cash flow per share (Unadj.) Rs14.218.2 78.2%  
Dividends per share (Unadj.) Rs07.50 0.0%  
Avg Dividend yield %01.5 0.0%  
Book value per share (Unadj.) Rs99.0193.6 51.1%  
Shares outstanding (eoy) m16.242,399.34 0.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.53.6 13.7%   
Avg P/E ratio x20.552.1 39.3%  
P/CF ratio (eoy) x6.527.3 23.7%  
Price / Book Value ratio x0.92.6 36.3%  
Dividend payout %078.8 0.0%   
Avg Mkt Cap Rs m1,4971,190,430 0.1%   
No. of employees `000NANA-   
Total wages/salary Rs m35868,622 0.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,073334,981 0.9%  
Other income Rs m238,592 0.3%   
Total revenues Rs m3,096343,573 0.9%   
Gross profit Rs m34641,616 0.8%  
Depreciation Rs m15820,800 0.8%   
Interest Rs m1091,414 7.7%   
Profit before tax Rs m10227,994 0.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m295,147 0.6%   
Profit after tax Rs m7322,847 0.3%  
Gross profit margin %11.312.4 90.6%  
Effective tax rate %28.518.4 154.9%   
Net profit margin %2.46.8 34.9%  
BALANCE SHEET DATA
Current assets Rs m1,918304,421 0.6%   
Current liabilities Rs m1,420161,456 0.9%   
Net working cap to sales %16.242.7 37.9%  
Current ratio x1.41.9 71.6%  
Inventory Days Days16149 10.5%  
Debtors Days Days85899 869.3%  
Net fixed assets Rs m1,304336,682 0.4%   
Share capital Rs m1622,399 6.8%   
"Free" reserves Rs m1,445462,229 0.3%   
Net worth Rs m1,608464,628 0.3%   
Long term debt Rs m2188,981 2.4%   
Total assets Rs m3,222641,103 0.5%  
Interest coverage x1.920.8 9.3%   
Debt to equity ratio x0.10 702.5%  
Sales to assets ratio x1.00.5 182.5%   
Return on assets %5.73.8 149.4%  
Return on equity %4.64.9 92.6%  
Return on capital %11.66.2 186.4%  
Exports to sales %67.40-   
Imports to sales %4.10-   
Exports (fob) Rs m2,072NA-   
Imports (cif) Rs m127NA-   
Fx inflow Rs m2,14084,493 2.5%   
Fx outflow Rs m12730,334 0.4%   
Net fx Rs m2,01254,159 3.7%   
CASH FLOW
From Operations Rs m31961,704 0.5%  
From Investments Rs m-595,362 -1.1%  
From Financial Activity Rs m-260-59,805 0.4%  
Net Cashflow Rs m-15,964 -0.0%  

Share Holding

Indian Promoters % 33.3 54.5 61.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 34.5 -  
FIIs % 0.0 14.4 -  
ADR/GDR % 0.0 0.0 -  
Free float % 66.7 45.5 146.6%  
Shareholders   3,561 662,384 0.5%  
Pledged promoter(s) holding % 0.0 5.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZIM LABORATORIES With:   CIPLA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    



Today's Market

4 Reasons Why Sensex Rallied 1,534 Points Today(0)

Bulls marked a strong comeback today as Indian share markets ended nearly 3% higher. After opening the day higher, equity markets extended gains as the session progressed and ended near the day's high.

Related Views on News

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

Sun Pharma Zooms 10% as June Quarter Earnings Beat Estimates (Views On News)

Jul 30, 2021

Here's a rundown on Sun Pharma's June quarter results.

Sun Pharma's Stock Falls 4% After Its March Quarter Results (Views On News)

May 28, 2021

In the past three months, the stock has outperformed the market by gaining nearly 20%. Can it go higher?

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far...(Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022(Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022(Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look...(Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better?(Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ZIM LABORATORIES SHARE PRICE


May 20, 2022 (Close)

TRACK ZIM LABORATORIES

  • Track your investment in ZIM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ZIM LABORATORIES

ZIM LABORATORIES 8-QTR ANALYSIS

COMPARE ZIM LABORATORIES WITH

MARKET STATS